Host and Viral Factors in Respiratory Syncytial Virus Infection

Respiratory syncytial virus (RSV) is a major worldwide pathogen for which there is still no effective vaccine or antiviral treatment available, and immunoprophylaxis with RSV-specific antibodies (e.g., palivizumab) is used in limited clinical settings. In this review, we discuss virus–host interacti...

Descripción completa

Detalles Bibliográficos
Autores principales: Mastrangelo, Peter, Hegele, Richard G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2013
Materias:
Infectious Disease (MS Pasternack, Section Editor)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100662/
https://www.ncbi.nlm.nih.gov/pubmed/32226653
http://dx.doi.org/10.1007/s40124-013-0019-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7100662/
https://www.ncbi.nlm.nih.gov/pubmed/32226653
http://dx.doi.org/10.1007/s40124-013-0019-3

Ejemplares similares